Vanguard Capital Management’s Artelo Biosciences ARTL Stock Holding History
Bought
Maintained
Sold
Other funds holding ARTL
Vanguard Capital Management's ARTL Position: Q3 2026 in Review
Vanguard Capital Management increased its Artelo Biosciences (ARTL) stake by 0.18% in Q3 2026, buying an estimated $14 and bringing the position to 1,127 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #4044.
Vanguard Capital Management first reported a position in ARTL in Q1 2026 and has held it in 3 quarters since. The position peaked at $76.8K in Q1 2026. 8 funds tracked by Wall St. Rank hold ARTL as of Q3 2026.
- Vanguard Capital Management held 1,127 shares of Artelo Biosciences worth $4.55K as of Q3 2026.
- Vanguard Capital Management bought 2 Artelo Biosciences shares in Q3 2026, an estimated $14.
- Artelo Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4044 holding.
- Vanguard Capital Management first reported a position in Artelo Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Artelo Biosciences position peaked at $76.8K in Q1 2026.
- 8 funds tracked by Wall St. Rank held Artelo Biosciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.